Two Promising Malaria Treatments Offer New Hope as Drug Resistance Rises

Two new approaches show promise against malaria: Novartis' GanLum (ganaplacide + lumefantrine) achieved a >97% cure rate in a 12-country African trial, while a Gabon study found a single-dose four-drug combo cl...


























